| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.11e-10 | 130 | 43 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | GTP binding | 1.79e-06 | 397 | 43 | 8 | GO:0005525 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 3.78e-06 | 439 | 43 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 3.78e-06 | 439 | 43 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.62e-04 | 9 | 43 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.62e-04 | 9 | 43 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 4.05e-04 | 14 | 43 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.53e-04 | 465 | 43 | 6 | GO:0046873 | |
| GeneOntologyMolecularFunction | structural molecule activity | 5.50e-04 | 891 | 43 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 6.04e-04 | 17 | 43 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 7.06e-04 | 81 | 43 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 7.57e-04 | 19 | 43 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.11e-03 | 23 | 43 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.42e-03 | 26 | 43 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.12e-03 | 627 | 43 | 6 | GO:0022890 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 2.14e-03 | 119 | 43 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 2.60e-03 | 884 | 43 | 7 | GO:0004930 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.83e-03 | 664 | 43 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | protein phosphatase 2A binding | 3.69e-03 | 42 | 43 | 2 | GO:0051721 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.71e-03 | 296 | 43 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | symporter activity | 4.12e-03 | 150 | 43 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.27e-03 | 152 | 43 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.41e-03 | 46 | 43 | 2 | GO:0005245 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 5.40e-03 | 758 | 43 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.92e-03 | 171 | 43 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 6.70e-03 | 793 | 43 | 6 | GO:0015075 | |
| GeneOntologyMolecularFunction | MHC protein binding | 6.94e-03 | 58 | 43 | 2 | GO:0042287 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.03e-03 | 182 | 43 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 7.25e-03 | 184 | 43 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | 7.51e-03 | 1353 | 43 | 8 | GO:0004888 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | TUBA1B TUBA3E ATM TUBA8 TUBA1A FZD3 CD28 TUBA4A TUBA3C TUBA3D TUBA1C | 4.03e-06 | 1014 | 42 | 11 | GO:0000278 |
| GeneOntologyBiologicalProcess | amino acid transport | 4.59e-05 | 195 | 42 | 5 | GO:0006865 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 8.74e-05 | 720 | 42 | 8 | GO:0000226 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.00e-04 | 230 | 42 | 5 | GO:0098739 | |
| GeneOntologyBiologicalProcess | response to pain | 1.53e-04 | 51 | 42 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.75e-04 | 259 | 42 | 5 | GO:0006836 | |
| GeneOntologyBiologicalProcess | organic cation transport | 2.13e-04 | 145 | 42 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | amino acid import across plasma membrane | 2.24e-04 | 58 | 42 | 3 | GO:0089718 | |
| GeneOntologyBiologicalProcess | microtubule-based process | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 2.29e-04 | 1058 | 42 | 9 | GO:0007017 |
| GeneOntologyBiologicalProcess | neuron-neuron synaptic transmission | 2.64e-04 | 12 | 42 | 2 | GO:0007270 | |
| GeneOntologyCellularComponent | microtubule | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 1.11e-06 | 533 | 43 | 9 | GO:0005874 |
| GeneOntologyCellularComponent | cell surface | SLC6A3 GHRHR SLC7A5 ADGRE2 ART1 CR2 KCNC4 ADGRG2 FZD3 LMO7 CD28 | 1.09e-05 | 1111 | 43 | 11 | GO:0009986 |
| GeneOntologyCellularComponent | presynapse | 6.52e-05 | 886 | 43 | 9 | GO:0098793 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 7.29e-05 | 899 | 43 | 9 | GO:0099513 |
| GeneOntologyCellularComponent | presynaptic membrane | 2.51e-04 | 277 | 43 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | neuronal cell body | 2.62e-04 | 835 | 43 | 8 | GO:0043025 | |
| GeneOntologyCellularComponent | axon | 4.06e-04 | 891 | 43 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | cell body | 5.36e-04 | 929 | 43 | 8 | GO:0044297 | |
| GeneOntologyCellularComponent | supramolecular fiber | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 5.54e-04 | 1179 | 43 | 9 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 5.82e-04 | 1187 | 43 | 9 | GO:0099081 |
| GeneOntologyCellularComponent | somatodendritic compartment | 7.43e-04 | 1228 | 43 | 9 | GO:0036477 | |
| GeneOntologyCellularComponent | axon terminus | 8.99e-04 | 210 | 43 | 4 | GO:0043679 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.32e-03 | 233 | 43 | 4 | GO:0044306 | |
| GeneOntologyCellularComponent | dendrite | 1.70e-03 | 858 | 43 | 7 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.72e-03 | 860 | 43 | 7 | GO:0097447 | |
| GeneOntologyCellularComponent | side of membrane | 1.90e-03 | 875 | 43 | 7 | GO:0098552 | |
| GeneOntologyCellularComponent | distal axon | 1.91e-03 | 435 | 43 | 5 | GO:0150034 | |
| GeneOntologyCellularComponent | lysosomal membrane | 2.49e-03 | 462 | 43 | 5 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.49e-03 | 462 | 43 | 5 | GO:0098852 | |
| GeneOntologyCellularComponent | cytoplasmic microtubule | 2.58e-03 | 133 | 43 | 3 | GO:0005881 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.04e-03 | 141 | 43 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | synaptic vesicle | 3.30e-03 | 300 | 43 | 4 | GO:0008021 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 3.54e-03 | 43 | 43 | 2 | GO:0032809 | |
| GeneOntologyCellularComponent | vacuolar membrane | 3.71e-03 | 507 | 43 | 5 | GO:0005774 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.04e-03 | 46 | 43 | 2 | GO:0005891 | |
| GeneOntologyCellularComponent | exocytic vesicle | 4.16e-03 | 320 | 43 | 4 | GO:0070382 | |
| GeneOntologyCellularComponent | cell body membrane | 4.21e-03 | 47 | 43 | 2 | GO:0044298 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 5.13e-03 | 785 | 43 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | late endosome membrane | 5.93e-03 | 179 | 43 | 3 | GO:0031902 | |
| GeneOntologyCellularComponent | lysosome | 5.99e-03 | 811 | 43 | 6 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 5.99e-03 | 811 | 43 | 6 | GO:0000323 | |
| GeneOntologyCellularComponent | membrane raft | 6.41e-03 | 362 | 43 | 4 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 6.54e-03 | 364 | 43 | 4 | GO:0098857 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.66e-03 | 583 | 43 | 5 | GO:0097060 | |
| GeneOntologyCellularComponent | leading edge membrane | 9.18e-03 | 210 | 43 | 3 | GO:0031256 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 9.44e-03 | 405 | 43 | 4 | GO:0045211 | |
| HumanPheno | Flushing | 2.23e-05 | 47 | 19 | 4 | HP:0031284 | |
| HumanPheno | Saccadic oscillation | 5.61e-05 | 21 | 19 | 3 | HP:0032104 | |
| MousePheno | decreased IgG2b level | 4.94e-07 | 70 | 32 | 5 | MP:0008497 | |
| MousePheno | abnormal IgG2b level | 5.58e-06 | 114 | 32 | 5 | MP:0020177 | |
| MousePheno | decreased IgG2 level | 7.17e-06 | 120 | 32 | 5 | MP:0013804 | |
| MousePheno | decreased IgG3 level | 3.17e-05 | 80 | 32 | 4 | MP:0008498 | |
| MousePheno | abnormal class switch recombination | 3.32e-05 | 81 | 32 | 4 | MP:0004816 | |
| MousePheno | decreased IgG2a level | 3.84e-05 | 84 | 32 | 4 | MP:0008496 | |
| MousePheno | increased taurine level | 5.06e-05 | 5 | 32 | 2 | MP:0030635 | |
| MousePheno | abnormal IgG2 level | 7.81e-05 | 197 | 32 | 5 | MP:0013802 | |
| MousePheno | abnormal germinal center B cell physiology | 1.06e-04 | 7 | 32 | 2 | MP:0008192 | |
| MousePheno | abnormal IgG3 level | 1.26e-04 | 114 | 32 | 4 | MP:0020179 | |
| MousePheno | decreased IgM level | 1.31e-04 | 115 | 32 | 4 | MP:0001806 | |
| MousePheno | abnormal IgM level | 1.40e-04 | 223 | 32 | 5 | MP:0020180 | |
| MousePheno | decreased IgG1 level | 1.98e-04 | 128 | 32 | 4 | MP:0008495 | |
| MousePheno | decreased IgG level | 2.21e-04 | 246 | 32 | 5 | MP:0001805 | |
| MousePheno | abnormal IgG2a level | 3.53e-04 | 149 | 32 | 4 | MP:0020176 | |
| MousePheno | abnormal Purkinje cell axon morphology | 3.90e-04 | 13 | 32 | 2 | MP:0014329 | |
| MousePheno | abnormal taurine level | 3.90e-04 | 13 | 32 | 2 | MP:0030634 | |
| MousePheno | short stride length | 5.15e-04 | 69 | 32 | 3 | MP:0001407 | |
| MousePheno | abnormal diencephalon morphology | 5.34e-04 | 298 | 32 | 5 | MP:0000830 | |
| MousePheno | abnormal inhibitory postsynaptic currents | 5.37e-04 | 70 | 32 | 3 | MP:0002945 | |
| MousePheno | abnormal thermal nociception | 5.57e-04 | 168 | 32 | 4 | MP:0002733 | |
| MousePheno | decreased response to antigen | 6.76e-04 | 17 | 32 | 2 | MP:0020001 | |
| MousePheno | decreased immunoglobulin level | 6.87e-04 | 315 | 32 | 5 | MP:0002460 | |
| MousePheno | increased amino acid level | 7.66e-04 | 79 | 32 | 3 | MP:0014527 | |
| MousePheno | abnormal frequency of paradoxical sleep | 8.47e-04 | 19 | 32 | 2 | MP:0003194 | |
| MousePheno | abnormal stride length | 8.53e-04 | 82 | 32 | 3 | MP:0012690 | |
| MousePheno | decreased somatotroph cell number | 1.04e-03 | 21 | 32 | 2 | MP:0008329 | |
| MousePheno | abnormal IgG1 level | 1.07e-03 | 200 | 32 | 4 | MP:0020175 | |
| MousePheno | abnormal circulating sodium level | 1.09e-03 | 201 | 32 | 4 | MP:0001776 | |
| MousePheno | decreased vertical activity | 1.13e-03 | 203 | 32 | 4 | MP:0002757 | |
| Domain | Alpha_tubulin | 6.16e-18 | 9 | 42 | 7 | IPR002452 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 2.86e-14 | 22 | 42 | 7 | IPR018316 | |
| Domain | Tubulin_C | 2.86e-14 | 22 | 42 | 7 | SM00865 | |
| Domain | Tubulin_C | 2.86e-14 | 22 | 42 | 7 | PF03953 | |
| Domain | Tubulin_C | 4.10e-14 | 23 | 42 | 7 | IPR023123 | |
| Domain | TUBULIN | 4.10e-14 | 23 | 42 | 7 | PS00227 | |
| Domain | Tubulin | 4.10e-14 | 23 | 42 | 7 | IPR000217 | |
| Domain | Tub_FtsZ_C | 4.10e-14 | 23 | 42 | 7 | IPR008280 | |
| Domain | Tubulin | 4.10e-14 | 23 | 42 | 7 | SM00864 | |
| Domain | Tubulin_CS | 4.10e-14 | 23 | 42 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 5.78e-14 | 24 | 42 | 7 | IPR003008 | |
| Domain | Tubulin | 5.78e-14 | 24 | 42 | 7 | PF00091 | |
| Domain | - | 3.37e-12 | 20 | 42 | 6 | 3.30.1330.20 | |
| Domain | - | 4.71e-12 | 21 | 42 | 6 | 1.10.287.600 | |
| Domain | - | 6.47e-12 | 22 | 42 | 6 | 3.40.50.1440 | |
| Domain | GPCR_2-like | 9.83e-06 | 60 | 42 | 4 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 9.83e-06 | 60 | 42 | 4 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.05e-05 | 61 | 42 | 4 | PS50261 | |
| Domain | GPCR_2_secretin-like_CS | 6.03e-05 | 34 | 42 | 3 | IPR017983 | |
| Domain | GPHH_dom | 1.03e-04 | 7 | 42 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 1.03e-04 | 7 | 42 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 1.03e-04 | 7 | 42 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 1.03e-04 | 7 | 42 | 2 | PF08763 | |
| Domain | GPHH | 1.03e-04 | 7 | 42 | 2 | PF16905 | |
| Domain | MARCH-like | 1.37e-04 | 8 | 42 | 2 | IPR033275 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.93e-04 | 50 | 42 | 3 | PS00650 | |
| Domain | 7tm_2 | 1.93e-04 | 50 | 42 | 3 | PF00002 | |
| Domain | VDCCAlpha1 | 2.20e-04 | 10 | 42 | 2 | IPR002077 | |
| Domain | RINGv | 2.68e-04 | 11 | 42 | 2 | PF12906 | |
| Domain | ZF_RING_CH | 2.68e-04 | 11 | 42 | 2 | PS51292 | |
| Domain | Channel_four-helix_dom | 2.84e-04 | 57 | 42 | 3 | IPR027359 | |
| Domain | - | 2.84e-04 | 57 | 42 | 3 | 1.20.120.350 | |
| Domain | Znf_RING-CH | 6.57e-04 | 17 | 42 | 2 | IPR011016 | |
| Domain | RINGv | 6.57e-04 | 17 | 42 | 2 | SM00744 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 7.38e-04 | 18 | 42 | 2 | PS00754 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 8.24e-04 | 19 | 42 | 2 | PS50267 | |
| Domain | SNF | 8.24e-04 | 19 | 42 | 2 | PF00209 | |
| Domain | Na/ntran_symport | 8.24e-04 | 19 | 42 | 2 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 8.24e-04 | 19 | 42 | 2 | PS00610 | |
| Domain | Ion_trans_dom | 2.14e-03 | 114 | 42 | 3 | IPR005821 | |
| Domain | Ion_trans | 2.14e-03 | 114 | 42 | 3 | PF00520 | |
| Domain | GPS | 2.65e-03 | 34 | 42 | 2 | SM00303 | |
| Domain | GPS | 2.80e-03 | 35 | 42 | 2 | PF01825 | |
| Domain | GPS | 2.96e-03 | 36 | 42 | 2 | PS50221 | |
| Domain | GPS | 3.13e-03 | 37 | 42 | 2 | IPR000203 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 3.03e-17 | 17 | 38 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 5.44e-17 | 18 | 38 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 9.38e-17 | 19 | 38 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 9.38e-17 | 19 | 38 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 1.56e-16 | 20 | 38 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 1.56e-16 | 20 | 38 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 2.52e-16 | 21 | 38 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 2.52e-16 | 21 | 38 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 3.94e-16 | 22 | 38 | 8 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 6.04e-16 | 23 | 38 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 6.04e-16 | 23 | 38 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 6.04e-16 | 23 | 38 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 9.04e-16 | 24 | 38 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 9.04e-16 | 24 | 38 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.33e-15 | 25 | 38 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.33e-15 | 25 | 38 | 8 | M47710 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.91e-15 | 26 | 38 | 8 | M47672 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.91e-15 | 26 | 38 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 3.79e-15 | 28 | 38 | 8 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 5.23e-15 | 29 | 38 | 8 | M27948 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 1.27e-14 | 32 | 38 | 8 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.27e-14 | 32 | 38 | 8 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 1.68e-14 | 33 | 38 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 1.68e-14 | 33 | 38 | 8 | M47901 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 2.83e-14 | 35 | 38 | 8 | M47774 | |
| Pathway | REACTOME_KINESINS | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 4.25e-14 | 61 | 38 | 9 | M977 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 5.85e-14 | 38 | 38 | 8 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.72e-13 | 43 | 38 | 8 | M47669 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 1.72e-13 | 43 | 38 | 8 | M47773 | |
| Pathway | REACTOME_AGGREPHAGY | 2.10e-13 | 44 | 38 | 8 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 2.10e-13 | 44 | 38 | 8 | M27934 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 2.55e-13 | 45 | 38 | 8 | M47670 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 3.08e-13 | 46 | 38 | 8 | M27828 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 5.29e-13 | 49 | 38 | 8 | M891 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 7.43e-13 | 51 | 38 | 8 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 1.03e-12 | 53 | 38 | 8 | M27651 | |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.41e-12 | 55 | 38 | 8 | M39613 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 1.64e-12 | 90 | 38 | 9 | M29841 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 1.64e-12 | 56 | 38 | 8 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.91e-12 | 57 | 38 | 8 | M27251 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 3.07e-12 | 17 | 38 | 6 | MM14731 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | SLC6A3 CACNA1A CACNA1B TUBA1B TUBA3E SLC6A13 TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 3.32e-12 | 270 | 38 | 12 | M15514 |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 4.33e-12 | 100 | 38 | 9 | M27650 |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 1.20e-11 | 71 | 38 | 8 | M39690 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 1.34e-11 | 72 | 38 | 8 | M26954 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.10e-11 | 76 | 38 | 8 | M27215 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.10e-11 | 76 | 38 | 8 | M48037 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | SLC6A3 CACNA1A CACNA1B TUBA1B TUBA3E SLC6A13 TUBA8 KCNC4 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 2.54e-11 | 411 | 38 | 13 | M735 |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 2.89e-11 | 79 | 38 | 8 | M27743 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | TUBA1B TUBA3E MGAT3 MIA2 TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 4.54e-11 | 187 | 38 | 10 | M961 |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 6.24e-11 | 134 | 38 | 9 | M27751 |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 7.20e-11 | 27 | 38 | 6 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 7.20e-11 | 27 | 38 | 6 | MM15674 | |
| Pathway | KEGG_GAP_JUNCTION | 8.40e-11 | 90 | 38 | 8 | M4013 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.15e-10 | 29 | 38 | 6 | MM15219 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.20e-10 | 94 | 38 | 8 | M2843 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.31e-10 | 95 | 38 | 8 | M6729 | |
| Pathway | REACTOME_KINESINS | 1.38e-10 | 57 | 38 | 7 | MM15714 | |
| Pathway | REACTOME_PROTEIN_FOLDING | 1.68e-10 | 98 | 38 | 8 | M776 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 2.18e-10 | 32 | 38 | 6 | MM14730 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.32e-10 | 102 | 38 | 8 | M27648 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 2.45e-10 | 156 | 38 | 9 | M27097 | |
| Pathway | REACTOME_AUTOPHAGY | 2.74e-10 | 158 | 38 | 9 | M27935 | |
| Pathway | REACTOME_AGGREPHAGY | 4.66e-10 | 36 | 38 | 6 | MM15669 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 5.27e-10 | 170 | 38 | 9 | M941 |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 5.55e-10 | 37 | 38 | 6 | MM15102 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 8.26e-10 | 73 | 38 | 7 | MM15672 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 9.20e-10 | 121 | 38 | 8 | M872 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.27e-09 | 126 | 38 | 8 | M705 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 1.35e-09 | 127 | 38 | 8 | M27181 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.63e-09 | 20 | 38 | 5 | MM1383 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.66e-09 | 44 | 38 | 6 | MM14606 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | TUBA1B TUBA3E TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D KIF1B TUBA1C | 2.53e-09 | 203 | 38 | 9 | M27654 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 2.63e-09 | 138 | 38 | 8 | M29805 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 2.87e-09 | 48 | 38 | 6 | MM15353 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 2.94e-09 | 140 | 38 | 8 | M27550 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 4.72e-09 | 52 | 38 | 6 | MM14949 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 5.36e-09 | 151 | 38 | 8 | M550 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | TUBA1B TUBA3E MGAT3 MIA2 TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 5.71e-09 | 307 | 38 | 10 | M894 |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 5.96e-09 | 54 | 38 | 6 | M27482 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 6.68e-09 | 98 | 38 | 7 | MM15352 | |
| Pathway | REACTOME_HCMV_INFECTION | 9.33e-09 | 162 | 38 | 8 | M29804 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 2.05e-08 | 66 | 38 | 6 | MM17074 | |
| Pathway | REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION | 2.18e-08 | 116 | 38 | 7 | MM15715 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.27e-08 | 261 | 38 | 9 | M42565 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 2.46e-08 | 68 | 38 | 6 | MM14921 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.46e-08 | 68 | 38 | 6 | MM14968 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 3.39e-08 | 191 | 38 | 8 | M29614 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 3.79e-08 | 73 | 38 | 6 | MM15491 | |
| Pathway | REACTOME_MACROAUTOPHAGY | 4.80e-08 | 130 | 38 | 7 | MM14627 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 4.84e-08 | 200 | 38 | 8 | M864 | |
| Pathway | REACTOME_CILIUM_ASSEMBLY | 5.04e-08 | 201 | 38 | 8 | M27472 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 5.06e-08 | 131 | 38 | 7 | MM15497 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 5.23e-08 | 202 | 38 | 8 | MM15650 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 5.65e-08 | 204 | 38 | 8 | M4217 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 5.87e-08 | 205 | 38 | 8 | M752 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 1.34e-07 | 90 | 38 | 6 | MM14979 | |
| Pathway | WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS | 1.53e-07 | 326 | 38 | 9 | M39379 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 1.74e-07 | 236 | 38 | 8 | M27185 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.74e-07 | 94 | 38 | 6 | MM14515 | |
| Pubmed | 2.46e-23 | 9 | 43 | 8 | 21167302 | ||
| Pubmed | 2.05e-19 | 19 | 43 | 8 | 15691386 | ||
| Pubmed | 2.05e-19 | 19 | 43 | 8 | 15698476 | ||
| Pubmed | 8.63e-19 | 22 | 43 | 8 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 6.94e-17 | 8 | 43 | 6 | 16148047 | |
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 4.44e-16 | 22 | 43 | 7 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 2.28e-15 | 12 | 43 | 6 | 15331610 | |
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 4.23e-15 | 13 | 43 | 6 | 10908577 | |
| Pubmed | 7.40e-15 | 14 | 43 | 6 | 12486001 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 1.36e-14 | 6 | 43 | 5 | 7651436 | |
| Pubmed | 1.36e-14 | 6 | 43 | 5 | 16327313 | ||
| Pubmed | 1.36e-14 | 6 | 43 | 5 | 3785200 | ||
| Pubmed | 4.76e-14 | 7 | 43 | 5 | 11146551 | ||
| Pubmed | 1.82e-13 | 22 | 43 | 6 | 15103018 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 2.85e-13 | 9 | 43 | 5 | 11953448 | |
| Pubmed | 2.02e-12 | 4 | 43 | 4 | 18400243 | ||
| Pubmed | 1.39e-11 | 17 | 43 | 5 | 17360745 | ||
| Pubmed | 7.07e-11 | 7 | 43 | 4 | 36681692 | ||
| Pubmed | 2.02e-10 | 212 | 43 | 8 | 23463506 | ||
| Pubmed | 5.21e-10 | 239 | 43 | 8 | 23246001 | ||
| Pubmed | 1.44e-09 | 13 | 43 | 4 | 14697242 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 1.76e-09 | 3 | 43 | 3 | 9722999 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 11163133 | ||
| Pubmed | 1.86e-09 | 94 | 43 | 6 | 36584595 | ||
| Pubmed | 4.62e-09 | 50 | 43 | 5 | 23703321 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 3.51e-08 | 6 | 43 | 3 | 35324301 | |
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 10840040 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 18613978 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 12090300 | ||
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 6.20e-08 | 288 | 43 | 7 | 31501420 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 1.42e-07 | 98 | 43 | 5 | 21942715 | |
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 19103752 | ||
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 2.88e-07 | 11 | 43 | 3 | 20405035 | |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 4.77e-07 | 125 | 43 | 5 | 36030824 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.01e-06 | 271 | 43 | 6 | 32433965 | |
| Pubmed | Structural features and restricted expression of a human alpha-tubulin gene. | 1.49e-06 | 2 | 43 | 2 | 3839072 | |
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.49e-06 | 2 | 43 | 2 | 23426690 | |
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 1.49e-06 | 2 | 43 | 2 | 24268707 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 23376566 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 38155373 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 22296162 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 25328666 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 21757542 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 15050706 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 12054644 | ||
| Pubmed | 2.31e-06 | 21 | 43 | 3 | 36332009 | ||
| Pubmed | TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology. | 2.67e-06 | 22 | 43 | 3 | 30446499 | |
| Pubmed | 2.75e-06 | 322 | 43 | 6 | 26514267 | ||
| Pubmed | 2.97e-06 | 513 | 43 | 7 | 25798074 | ||
| Pubmed | 3.81e-06 | 85 | 43 | 4 | 23055939 | ||
| Pubmed | Identification of alpha-tubulin as an hsp105alpha-binding protein by the yeast two-hybrid system. | 4.48e-06 | 3 | 43 | 2 | 12749852 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 27503069 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 31767681 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 12087096 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 29466725 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 8566014 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 23606747 | ||
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 4.48e-06 | 3 | 43 | 2 | 24394417 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 9885248 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 19409876 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 11082048 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 38299743 | ||
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 38996073 | ||
| Pubmed | Expression of human alpha-tubulin genes: interspecies conservation of 3' untranslated regions. | 4.48e-06 | 3 | 43 | 2 | 6646120 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 23300075 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 4.48e-06 | 3 | 43 | 2 | 24523520 | |
| Pubmed | The role of Tuba1a in adult hippocampal neurogenesis and the formation of the dentate gyrus. | 4.48e-06 | 3 | 43 | 2 | 21041996 | |
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 4.48e-06 | 3 | 43 | 2 | 29208674 | |
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 4.48e-06 | 3 | 43 | 2 | 26507659 | |
| Pubmed | 5.57e-06 | 206 | 43 | 5 | 22174317 | ||
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 5.94e-06 | 95 | 43 | 4 | 27129302 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 8.94e-06 | 4 | 43 | 2 | 32616470 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 26283199 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 27503071 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 28555754 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 19117940 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 15728831 | ||
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 8.94e-06 | 4 | 43 | 2 | 25483588 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 16216085 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 8.94e-06 | 4 | 43 | 2 | 37141091 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 12024216 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 31253182 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 12629046 | ||
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 9372968 | ||
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 8.94e-06 | 4 | 43 | 2 | 15953418 | |
| Pubmed | 8.94e-06 | 4 | 43 | 2 | 17389232 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.05e-05 | 235 | 43 | 5 | 28378594 | |
| Pubmed | Viral immune modulators perturb the human molecular network by common and unique strategies. | 1.31e-05 | 116 | 43 | 4 | 22810585 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 1.33e-05 | 37 | 43 | 3 | 25798587 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 8825650 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 28388629 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 16787652 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 15129282 | ||
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 15451373 | ||
| Pubmed | Five mouse tubulin isotypes and their regulated expression during development. | 1.49e-05 | 5 | 43 | 2 | 3839797 | |
| Pubmed | Tuba8 is expressed at low levels in the developing mouse and human brain. | 1.49e-05 | 5 | 43 | 2 | 20466094 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 11826099 | ||
| Pubmed | HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. | 1.49e-05 | 5 | 43 | 2 | 12606581 | |
| Pubmed | Prefoldin recognition motifs in the nonhomologous proteins of the actin and tubulin families. | 1.49e-05 | 5 | 43 | 2 | 11535601 | |
| Interaction | TCP11L2 interactions | 2.83e-17 | 21 | 41 | 8 | int:TCP11L2 | |
| Interaction | GRM7 interactions | 3.08e-10 | 19 | 41 | 5 | int:GRM7 | |
| Interaction | CD81 interactions | 8.01e-09 | 303 | 41 | 9 | int:CD81 | |
| Interaction | UBL4A interactions | TUBA1B TUBA3E TUBA8 TUBA1A DIABLO TUBA3C TUBA3D TUBA1C WDR20 | 2.72e-08 | 349 | 41 | 9 | int:UBL4A |
| Interaction | LTA interactions | 2.91e-07 | 28 | 41 | 4 | int:LTA | |
| Interaction | BSG interactions | TUBA1B TUBA3E SLC7A5 ATM TUBA8 TUBA1A TUBA4A TUBA3C TUBA3D TUBA1C | 3.93e-07 | 631 | 41 | 10 | int:BSG |
| Interaction | CD86 interactions | 6.51e-07 | 9 | 41 | 3 | int:CD86 | |
| Interaction | PLA2G7 interactions | 6.51e-07 | 9 | 41 | 3 | int:PLA2G7 | |
| Interaction | BACE2 interactions | 6.58e-07 | 82 | 41 | 5 | int:BACE2 | |
| Interaction | NUP210P1 interactions | 1.56e-06 | 42 | 41 | 4 | int:NUP210P1 | |
| Interaction | TUBB2B interactions | 3.44e-06 | 205 | 41 | 6 | int:TUBB2B | |
| Interaction | CAPSL interactions | 3.50e-06 | 15 | 41 | 3 | int:CAPSL | |
| Interaction | TXNDC9 interactions | 5.10e-06 | 124 | 41 | 5 | int:TXNDC9 | |
| Interaction | PFDN4 interactions | 5.31e-06 | 125 | 41 | 5 | int:PFDN4 | |
| Interaction | SIAH1 interactions | 5.58e-06 | 223 | 41 | 6 | int:SIAH1 | |
| Interaction | VAV1 interactions | 6.34e-06 | 228 | 41 | 6 | int:VAV1 | |
| Interaction | PAK1 interactions | 6.50e-06 | 229 | 41 | 6 | int:PAK1 | |
| Interaction | YWHAZ interactions | DEPDC5 ATM TUBA1A LMO7 DIABLO CD28 TUBA3C SPEG KIF1B WDR20 SH2D3C ARG1 | 7.84e-06 | 1319 | 41 | 12 | int:YWHAZ |
| Interaction | ZC2HC1A interactions | 8.57e-06 | 64 | 41 | 4 | int:ZC2HC1A | |
| Interaction | TTC5 interactions | 9.12e-06 | 65 | 41 | 4 | int:TTC5 | |
| Interaction | STARD13 interactions | 1.09e-05 | 68 | 41 | 4 | int:STARD13 | |
| Interaction | TSPYL6 interactions | 1.09e-05 | 68 | 41 | 4 | int:TSPYL6 | |
| Interaction | GABRA1 interactions | 1.38e-05 | 152 | 41 | 5 | int:GABRA1 | |
| Interaction | BRINP3 interactions | 1.74e-05 | 25 | 41 | 3 | int:BRINP3 | |
| Interaction | CAPS interactions | 1.74e-05 | 25 | 41 | 3 | int:CAPS | |
| Interaction | ZC2HC1B interactions | 2.47e-05 | 28 | 41 | 3 | int:ZC2HC1B | |
| Interaction | TFCP2 interactions | 2.52e-05 | 436 | 41 | 7 | int:TFCP2 | |
| Interaction | KLK11 interactions | 5.33e-05 | 36 | 41 | 3 | int:KLK11 | |
| Interaction | VBP1 interactions | 5.51e-05 | 203 | 41 | 5 | int:VBP1 | |
| Interaction | ERRFI1 interactions | 6.54e-05 | 107 | 41 | 4 | int:ERRFI1 | |
| Interaction | INSYN2A interactions | 6.79e-05 | 39 | 41 | 3 | int:INSYN2A | |
| Interaction | CD48 interactions | 6.79e-05 | 39 | 41 | 3 | int:CD48 | |
| Interaction | MLLT11 interactions | 9.11e-05 | 43 | 41 | 3 | int:MLLT11 | |
| Interaction | PTH2R interactions | 9.89e-05 | 119 | 41 | 4 | int:PTH2R | |
| Interaction | ITGAD interactions | 1.12e-04 | 46 | 41 | 3 | int:ITGAD | |
| Interaction | PRSS50 interactions | 1.12e-04 | 46 | 41 | 3 | int:PRSS50 | |
| Interaction | SSR2 interactions | 1.12e-04 | 46 | 41 | 3 | int:SSR2 | |
| Interaction | DHDH interactions | 1.19e-04 | 47 | 41 | 3 | int:DHDH | |
| Interaction | NLRP1 interactions | 1.19e-04 | 47 | 41 | 3 | int:NLRP1 | |
| Interaction | TRAV20 interactions | 1.27e-04 | 48 | 41 | 3 | int:TRAV20 | |
| Interaction | TMPRSS5 interactions | 1.27e-04 | 48 | 41 | 3 | int:TMPRSS5 | |
| Interaction | IGHM interactions | 1.39e-04 | 130 | 41 | 4 | int:IGHM | |
| Interaction | NEK4 interactions | 1.55e-04 | 582 | 41 | 7 | int:NEK4 | |
| Interaction | PFN3 interactions | 1.80e-04 | 10 | 41 | 2 | int:PFN3 | |
| Interaction | LGR4 interactions | 1.83e-04 | 262 | 41 | 5 | int:LGR4 | |
| Interaction | HEY1 interactions | 1.85e-04 | 140 | 41 | 4 | int:HEY1 | |
| Interaction | CCT3 interactions | 1.94e-04 | 604 | 41 | 7 | int:CCT3 | |
| Interaction | SERPINB11 interactions | 2.20e-04 | 11 | 41 | 2 | int:SERPINB11 | |
| Interaction | GRAMD2A interactions | 2.20e-04 | 11 | 41 | 2 | int:GRAMD2A | |
| Interaction | NXPH3 interactions | 2.23e-04 | 58 | 41 | 3 | int:NXPH3 | |
| Interaction | LYPD1 interactions | 2.23e-04 | 58 | 41 | 3 | int:LYPD1 | |
| Interaction | INSL5 interactions | 2.23e-04 | 58 | 41 | 3 | int:INSL5 | |
| Interaction | NSUN5P1 interactions | 2.35e-04 | 59 | 41 | 3 | int:NSUN5P1 | |
| Interaction | NPTN interactions | 2.41e-04 | 278 | 41 | 5 | int:NPTN | |
| Interaction | ITLN1 interactions | 2.59e-04 | 61 | 41 | 3 | int:ITLN1 | |
| Interaction | ADGRG2 interactions | 2.63e-04 | 12 | 41 | 2 | int:ADGRG2 | |
| Interaction | LGALS2 interactions | 2.63e-04 | 12 | 41 | 2 | int:LGALS2 | |
| Interaction | NLRP7 interactions | 3.16e-04 | 161 | 41 | 4 | int:NLRP7 | |
| Interaction | SNX21 interactions | 3.42e-04 | 67 | 41 | 3 | int:SNX21 | |
| Interaction | CDHR4 interactions | 3.57e-04 | 68 | 41 | 3 | int:CDHR4 | |
| Interaction | LRRC23 interactions | 3.62e-04 | 14 | 41 | 2 | int:LRRC23 | |
| Interaction | NALCN interactions | 3.62e-04 | 14 | 41 | 2 | int:NALCN | |
| Interaction | UBAC2 interactions | 3.63e-04 | 167 | 41 | 4 | int:UBAC2 | |
| Interaction | PFDN6 interactions | 3.79e-04 | 169 | 41 | 4 | int:PFDN6 | |
| Interaction | TUBA1C interactions | 3.84e-04 | 478 | 41 | 6 | int:TUBA1C | |
| Interaction | FBXW5 interactions | 3.88e-04 | 170 | 41 | 4 | int:FBXW5 | |
| Interaction | BAGE2 interactions | 3.89e-04 | 70 | 41 | 3 | int:BAGE2 | |
| Interaction | DYRK2 interactions | 4.15e-04 | 173 | 41 | 4 | int:DYRK2 | |
| Interaction | SCN11A interactions | 4.17e-04 | 15 | 41 | 2 | int:SCN11A | |
| Interaction | CHKA interactions | 4.17e-04 | 15 | 41 | 2 | int:CHKA | |
| Interaction | TRAC interactions | 4.17e-04 | 15 | 41 | 2 | int:TRAC | |
| Interaction | ADAMTS4 interactions | 4.23e-04 | 72 | 41 | 3 | int:ADAMTS4 | |
| Interaction | PFDN5 interactions | 4.27e-04 | 315 | 41 | 5 | int:PFDN5 | |
| Interaction | ADARB1 interactions | 4.33e-04 | 489 | 41 | 6 | int:ADARB1 | |
| Interaction | GZMH interactions | 4.58e-04 | 74 | 41 | 3 | int:GZMH | |
| Interaction | FAM187B interactions | 4.76e-04 | 16 | 41 | 2 | int:FAM187B | |
| Interaction | TUBA1B interactions | 4.77e-04 | 498 | 41 | 6 | int:TUBA1B | |
| Interaction | CST11 interactions | 4.77e-04 | 75 | 41 | 3 | int:CST11 | |
| Interaction | TCP11L1 interactions | 4.77e-04 | 75 | 41 | 3 | int:TCP11L1 | |
| Interaction | PPP4R1 interactions | 4.96e-04 | 76 | 41 | 3 | int:PPP4R1 | |
| Interaction | F12 interactions | 5.15e-04 | 77 | 41 | 3 | int:F12 | |
| Interaction | LRRC25 interactions | 5.34e-04 | 185 | 41 | 4 | int:LRRC25 | |
| Interaction | SUV39H2 interactions | 5.35e-04 | 78 | 41 | 3 | int:SUV39H2 | |
| Interaction | TES interactions | 5.42e-04 | 332 | 41 | 5 | int:TES | |
| Interaction | PHLPP1 interactions | 5.50e-04 | 333 | 41 | 5 | int:PHLPP1 | |
| Interaction | TUBA4A interactions | 5.52e-04 | 512 | 41 | 6 | int:TUBA4A | |
| Interaction | CD80 interactions | 5.55e-04 | 79 | 41 | 3 | int:CD80 | |
| Interaction | ATOH1 interactions | 5.76e-04 | 80 | 41 | 3 | int:ATOH1 | |
| Interaction | OSTM1 interactions | 5.76e-04 | 80 | 41 | 3 | int:OSTM1 | |
| Interaction | TPSB2 interactions | 6.05e-04 | 18 | 41 | 2 | int:TPSB2 | |
| Interaction | LRP1 interactions | 6.63e-04 | 196 | 41 | 4 | int:LRP1 | |
| Interaction | B4GALT1 interactions | 6.64e-04 | 84 | 41 | 3 | int:B4GALT1 | |
| Interaction | GLMP interactions | 6.64e-04 | 84 | 41 | 3 | int:GLMP | |
| Interaction | CD3D interactions | 6.88e-04 | 85 | 41 | 3 | int:CD3D | |
| Interaction | TMEM263 interactions | 6.88e-04 | 85 | 41 | 3 | int:TMEM263 | |
| Interaction | IL12RB1 interactions | 7.36e-04 | 87 | 41 | 3 | int:IL12RB1 | |
| Interaction | KIR2DS3 interactions | 7.50e-04 | 20 | 41 | 2 | int:KIR2DS3 | |
| Interaction | HCST interactions | 7.84e-04 | 205 | 41 | 4 | int:HCST | |
| Interaction | CCT6B interactions | 8.13e-04 | 207 | 41 | 4 | int:CCT6B | |
| Interaction | SCN9A interactions | 8.27e-04 | 21 | 41 | 2 | int:SCN9A | |
| Cytoband | 12q13.12 | 6.31e-06 | 38 | 43 | 3 | 12q13.12 | |
| Cytoband | 2q21.1 | 1.37e-03 | 58 | 43 | 2 | 2q21.1 | |
| Cytoband | 2q35 | 2.52e-03 | 79 | 43 | 2 | 2q35 | |
| GeneFamily | Tubulins | 1.63e-16 | 26 | 36 | 8 | 778 | |
| GeneFamily | Ring finger proteins|Membrane associated ring-CH-type fingers | 2.10e-04 | 11 | 36 | 2 | 60 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.04e-03 | 394 | 36 | 5 | 471 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.22e-03 | 26 | 36 | 2 | 253 | |
| GeneFamily | Solute carriers | 7.61e-03 | 395 | 36 | 4 | 752 | |
| Coexpression | TOMIDA_METASTASIS_UP | 9.69e-06 | 26 | 42 | 3 | M17830 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 2.02e-05 | 33 | 42 | 3 | M7409 | |
| Coexpression | ALONSO_METASTASIS_EMT_UP | 2.42e-05 | 35 | 42 | 3 | M8191 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_B_CELL_AGEING | 3.32e-05 | 231 | 42 | 5 | MM3741 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN | 8.96e-05 | 54 | 42 | 3 | M1349 | |
| Coexpression | SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP | 1.08e-04 | 154 | 42 | 4 | M3766 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_UP | 1.11e-04 | 298 | 42 | 5 | M1918 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 1.44e-04 | 166 | 42 | 4 | M39026 | |
| Coexpression | JIANG_MELANOMA_TRM1_CD8 | 1.84e-04 | 177 | 42 | 4 | M48965 | |
| Coexpression | GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN | 2.56e-04 | 193 | 42 | 4 | M3149 | |
| Coexpression | GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP | 2.61e-04 | 194 | 42 | 4 | M4958 | |
| Coexpression | GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP | 2.77e-04 | 197 | 42 | 4 | M8170 | |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_DN | 2.77e-04 | 197 | 42 | 4 | M5462 | |
| Coexpression | GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN | 2.82e-04 | 198 | 42 | 4 | M3240 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN | 2.88e-04 | 199 | 42 | 4 | M7853 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN | 2.88e-04 | 199 | 42 | 4 | M8430 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN | 2.88e-04 | 199 | 42 | 4 | M8707 | |
| Coexpression | GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 2.93e-04 | 200 | 42 | 4 | M7776 | |
| Coexpression | GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN | 2.93e-04 | 200 | 42 | 4 | M5137 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP | 2.93e-04 | 200 | 42 | 4 | M9691 | |
| Coexpression | GSE27786_LIN_NEG_VS_CD4_TCELL_UP | 2.93e-04 | 200 | 42 | 4 | M4769 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP | 2.93e-04 | 200 | 42 | 4 | M3780 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN | 2.93e-04 | 200 | 42 | 4 | M10033 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.22e-07 | 170 | 43 | 5 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.96e-07 | 187 | 43 | 5 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 9.96e-07 | 187 | 43 | 5 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.66e-05 | 159 | 43 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic-Mast_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 160 | 43 | 4 | fe9970c160159b35f6599ed13c89cfb49264d554 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 167 | 43 | 4 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 169 | 43 | 4 | 88aa2246ede582c2e11de63228d76f520889ecb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 169 | 43 | 4 | a6a5b00912b653fad2ca7f096deaf35c9ef85e5b | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.11e-05 | 169 | 43 | 4 | 42a9b8c77d2a4d68b01e4db38f8a1af53c9c814f | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-05 | 170 | 43 | 4 | b04e2f84024baaae9b4ff19bdac8c69afdb92a76 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 172 | 43 | 4 | adf016e5856bc85e7bed58aee09ade483b9dcb00 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 2.48e-05 | 176 | 43 | 4 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 181 | 43 | 4 | d0637f9ccec5dba4997520b27287989522e04f96 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-05 | 181 | 43 | 4 | af031661af28f99d906d8e013b4949133b44a2e6 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 2.77e-05 | 181 | 43 | 4 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | wk_15-18-Hematologic-Meg-ery|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.83e-05 | 182 | 43 | 4 | 1adb8d6404d50155e9f9ba805abef63929fe865f | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 3.01e-05 | 185 | 43 | 4 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-05 | 187 | 43 | 4 | 99724aa3dbdcb073ea3bfe80cc825ecae5495db8 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 3.27e-05 | 189 | 43 | 4 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_TFH-like|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.48e-05 | 192 | 43 | 4 | 0f9cae41bb9bc9366efe9eb48e26b3e80c642879 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 192 | 43 | 4 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 192 | 43 | 4 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.55e-05 | 193 | 43 | 4 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.63e-05 | 194 | 43 | 4 | 22b87fe2bb84632ddcef8f1d7742021728e2246d | |
| ToppCell | medial-Hematologic-CD8+_Memory/Effector_T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.77e-05 | 196 | 43 | 4 | 252e15a4ea54d872c5b910711941dcdf359c0492 | |
| ToppCell | medial-Hematologic-CD8+_Memory/Effector_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.77e-05 | 196 | 43 | 4 | caef28955269f4f6fb323a74b6b73cff8db11272 | |
| ToppCell | medial-2-Hematologic-CD8+_Memory/Effector_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.77e-05 | 196 | 43 | 4 | e401d1683a13f2636e8fc0e22428a6a3653a1521 | |
| ToppCell | CV-Moderate-3|CV / Virus stimulation, Condition and Cluster | 3.85e-05 | 197 | 43 | 4 | 7031286e300eaccf73b927939f8de3a9d2d5fc74 | |
| ToppCell | Biopsy_IPF-Immune-B_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 3.93e-05 | 198 | 43 | 4 | 6a519337a4932a7b685fe7defd3de24fa2016b7d | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.93e-05 | 198 | 43 | 4 | d73585a5587941483db8d9ddc2d68f7d852bbbc8 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 199 | 43 | 4 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.08e-05 | 200 | 43 | 4 | 41a206350eff2a196ccc1a36a9636a87c74f6962 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.18e-04 | 138 | 43 | 3 | 8d70e64843f7c3be8ee4203cc126fdf1001f0df5 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.25e-04 | 139 | 43 | 3 | 7e2c10830c3d16109cab3ed0d64b3532481e497d | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.39e-04 | 141 | 43 | 3 | d3ce2218bfa9750795d920e1ef162ea44efb2e66 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.46e-04 | 142 | 43 | 3 | 94e277f038f4006d99ff50222b0f5cf89bc3d46d | |
| ToppCell | TCGA-Brain-Recurrent_Tumor|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.53e-04 | 143 | 43 | 3 | eeb8ce6e051e18b82b74aaf2fc23f0cb87fc96d5 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Erythro-cells / Lineage, cell class and subclass | 3.61e-04 | 144 | 43 | 3 | 7fbedc65314cfb06bcc527d794b5de7858f7c5ec | |
| ToppCell | Control-Myeloid-Dendritic_cells-pDC|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.68e-04 | 145 | 43 | 3 | bab85a72142b6257f7d424e5301f65b6dcdf745d | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.76e-04 | 146 | 43 | 3 | 45d7cb73776e60d22f335a651845e21e16948fcc | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-04 | 149 | 43 | 3 | a464c0fd54e3c9e1d40d95b49489cb9371dd7c24 | |
| ToppCell | facs-Trachea-nan-24m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 151 | 43 | 3 | 26fd55efb647c41436416d45952ee97b050e632c | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT1_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 4.39e-04 | 154 | 43 | 3 | 8a643d91896af9b630a715fb284c1523d01ad1a3 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-04 | 155 | 43 | 3 | cc3fc379ea78742a216317054f336331f7c7a157 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-04 | 155 | 43 | 3 | 1900a76754e2a9c7117e531c5907b7942f72c4a6 | |
| ToppCell | Monocytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 4.47e-04 | 155 | 43 | 3 | 82abfcee23ba08a1eb4208d367393285026e5388 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.64e-04 | 157 | 43 | 3 | 2c767c526abcc8adea6ec4eb2cc333060bb213b5 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 157 | 43 | 3 | 3c6be6995c00c4cadbd209c66bf9a87c8c238652 | |
| ToppCell | facs-Marrow-KLS-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.64e-04 | 157 | 43 | 3 | 662d5026e0e4249029fc6f3abc771d775d7bc3bb | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.64e-04 | 157 | 43 | 3 | 188d2f85babcd4eefe20e7a392d851b2e1185bab | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.82e-04 | 159 | 43 | 3 | f7bccfeffa737f151417bf52ea45111b0957bce9 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.82e-04 | 159 | 43 | 3 | 5c7a099aa84ecc62bf9b5e1609e5b6b77889f175 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.91e-04 | 160 | 43 | 3 | 30b7f24e0c3ecfa618b4e31678e18c8a4405a8d7 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 160 | 43 | 3 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 160 | 43 | 3 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 160 | 43 | 3 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 160 | 43 | 3 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 160 | 43 | 3 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.91e-04 | 160 | 43 | 3 | 21f7c0337fbd99e4a20650920d8302d7318bd25e | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 161 | 43 | 3 | 8e787cc7f5e818cad1a6ed143a5fe310993e030b | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-CD8+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 161 | 43 | 3 | ca9233370490e27b9a1892669d6b82db2136180e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-04 | 162 | 43 | 3 | 8ed9149ff53b285591354057055d072b203a47c8 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 162 | 43 | 3 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-04 | 162 | 43 | 3 | 7a05b05a33e1309fb5c0a8171db105ae68491815 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.09e-04 | 162 | 43 | 3 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 162 | 43 | 3 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-04 | 162 | 43 | 3 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.18e-04 | 163 | 43 | 3 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 164 | 43 | 3 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-04 | 164 | 43 | 3 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | B_cells-ABCs|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.27e-04 | 164 | 43 | 3 | f45013706a917f0f0d69c23f288128f252cd60c7 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-04 | 165 | 43 | 3 | dba630e205eb3725195f8861e4af5b745ccfdc74 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.37e-04 | 165 | 43 | 3 | 004d793bf5bb6fb3b7bf38baf11b32d46375fe4d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-04 | 165 | 43 | 3 | a508d66031c1a46b062afbee3cde1cbd0c163a03 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-04 | 165 | 43 | 3 | b03c8c3110f32257e78838885b313a922af73c98 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.46e-04 | 166 | 43 | 3 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | normal_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lung / Location, Cell class and cell subclass | 5.46e-04 | 166 | 43 | 3 | ff32422390852546e0cb216192452e9c47bd9509 | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-04 | 166 | 43 | 3 | c0fd3f3f5c3412746da279b856af0d28b9b70c5d | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-04 | 166 | 43 | 3 | 33c4876df43b4c1d100699bca47459918bd054d6 | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-04 | 166 | 43 | 3 | ac9b9df57d65ccbbf9ae3add50c5663efcd30dcb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-04 | 167 | 43 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 167 | 43 | 3 | 713899690e4acd9d259645e363c26983d6ef3022 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.56e-04 | 167 | 43 | 3 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 167 | 43 | 3 | d30b96c39da3dd02500443877a4eb3500e26802c | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-04 | 168 | 43 | 3 | 9d6ca10c272aea28082c09d469940f7232f6461c | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-04 | 168 | 43 | 3 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-04 | 169 | 43 | 3 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | Control-Hematopoietic_Meg-Ery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.75e-04 | 169 | 43 | 3 | c2e2a7b89fe4a64d79efafdec037c4104f433061 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-04 | 169 | 43 | 3 | c3d410a5e98000ba872141b62e17ef4ed3d1a8eb | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.75e-04 | 169 | 43 | 3 | df1fc1477bbbb285063b9b122b1ac84c87fd7fa8 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Erythroid-Erythroid|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.75e-04 | 169 | 43 | 3 | 92986559aa4a744e8b0487b0ae035cfb1fbf9890 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-04 | 169 | 43 | 3 | e36b8cd0230bbb761df7606129ebfd77111af10b | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-04 | 37 | 43 | 2 | 5208860d6b87c6c6fbf6e6c262fb2efc712ec2d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-04 | 170 | 43 | 3 | 28fb192b21cdc5a77ba4f276694cff852eb2304b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-04 | 170 | 43 | 3 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.85e-04 | 170 | 43 | 3 | 02f0be0aab8ba2d35a83238609352ef3677511c9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-04 | 170 | 43 | 3 | 239cb4b801b2d71a6facb386f2684c0851504151 | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.85e-04 | 170 | 43 | 3 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.95e-04 | 171 | 43 | 3 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| Drug | Epothilone D | 2.89e-14 | 12 | 43 | 6 | DB01873 | |
| Drug | Epothilone B | 2.89e-14 | 12 | 43 | 6 | DB03010 | |
| Drug | NSC72302 | 1.15e-11 | 28 | 43 | 6 | CID000118078 | |
| Drug | Aids106696 | 1.45e-11 | 29 | 43 | 6 | CID006475933 | |
| Drug | bromocolchicine | 3.76e-10 | 21 | 43 | 5 | CID000161518 | |
| Drug | Ustiloxin A | 3.76e-10 | 21 | 43 | 5 | CID000164454 | |
| Drug | SRI-3072 | 3.76e-10 | 21 | 43 | 5 | CID000493469 | |
| Drug | colchifoline | 3.76e-10 | 21 | 43 | 5 | CID000100132 | |
| Drug | procaine | 4.11e-10 | 153 | 43 | 8 | CID000004914 | |
| Drug | 3,4,5-trimethoxyacetophenone | 4.86e-10 | 22 | 43 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 4.86e-10 | 22 | 43 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 4.86e-10 | 22 | 43 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 4.86e-10 | 22 | 43 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 4.86e-10 | 22 | 43 | 5 | CID000023759 | |
| Drug | NSC-339672 | 4.86e-10 | 22 | 43 | 5 | CID000433930 | |
| Drug | IKP104 | 6.20e-10 | 23 | 43 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 6.20e-10 | 23 | 43 | 5 | CID003035871 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 6.20e-10 | 23 | 43 | 5 | CID000006858 | |
| Drug | 3-demethylthiocolchicine | 6.20e-10 | 23 | 43 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 6.20e-10 | 23 | 43 | 5 | CID000129239 | |
| Drug | AC1L2P05 | 6.20e-10 | 23 | 43 | 5 | CID000125688 | |
| Drug | 2,3,4-tabp | 6.20e-10 | 23 | 43 | 5 | CID000125548 | |
| Drug | NSC-373301 | 6.20e-10 | 23 | 43 | 5 | CID000341375 | |
| Drug | N-acetylcolchinol | 6.20e-10 | 23 | 43 | 5 | CID000097865 | |
| Drug | NSC355636 | 6.20e-10 | 23 | 43 | 5 | CID000100176 | |
| Drug | moscatilin | 7.82e-10 | 24 | 43 | 5 | CID000176096 | |
| Drug | parbendazole | 7.82e-10 | 24 | 43 | 5 | CID000026596 | |
| Drug | NSC-36768 | 7.82e-10 | 24 | 43 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 7.82e-10 | 24 | 43 | 5 | CID000014995 | |
| Drug | tropolone methyl ether | 7.82e-10 | 24 | 43 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 7.82e-10 | 24 | 43 | 5 | CID000330401 | |
| Drug | NABV | 7.82e-10 | 24 | 43 | 5 | CID000175959 | |
| Drug | colchicide | 7.82e-10 | 24 | 43 | 5 | CID000120712 | |
| Drug | AC1L4TG7 | 7.82e-10 | 24 | 43 | 5 | CID000163705 | |
| Drug | 2,5-hexanedione | 9.55e-10 | 56 | 43 | 6 | CID000008035 | |
| Drug | NBD-colcemid | 9.76e-10 | 25 | 43 | 5 | CID000130594 | |
| Drug | mpMap | 9.76e-10 | 25 | 43 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 9.76e-10 | 25 | 43 | 5 | CID000160263 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 9.76e-10 | 25 | 43 | 5 | CID000043264 | |
| Drug | allocolchicine | 9.76e-10 | 25 | 43 | 5 | CID000196989 | |
| Drug | 1069C85 | 9.76e-10 | 25 | 43 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 9.76e-10 | 25 | 43 | 5 | CID006438440 | |
| Drug | CA1P | 9.76e-10 | 25 | 43 | 5 | CID006918545 | |
| Drug | peloruside A | 9.76e-10 | 25 | 43 | 5 | CID006918506 | |
| Drug | NSC142227 | 9.76e-10 | 25 | 43 | 5 | CID000073427 | |
| Drug | MDL 27048 | 9.76e-10 | 25 | 43 | 5 | CID006439188 | |
| Drug | NSC527981 | 1.21e-09 | 26 | 43 | 5 | CID000352796 | |
| Drug | NSC332029 | 1.21e-09 | 26 | 43 | 5 | CID000100073 | |
| Drug | indibulin | 1.21e-09 | 26 | 43 | 5 | CID000002929 | |
| Drug | pironetin | 1.21e-09 | 26 | 43 | 5 | CID006438891 | |
| Drug | isaxonine | 1.21e-09 | 26 | 43 | 5 | CID000071169 | |
| Drug | AC1L1J4H | 1.48e-09 | 27 | 43 | 5 | CID000004862 | |
| Drug | NSC292222 | 1.48e-09 | 27 | 43 | 5 | CID000099957 | |
| Drug | dinitroanilines | 1.48e-09 | 27 | 43 | 5 | CID000136400 | |
| Drug | NSC D-669356 | 1.48e-09 | 27 | 43 | 5 | CID000178028 | |
| Drug | valproate | SLC6A3 CACNA1A CACNA1B TUBA3E TUBA8 KCNC4 TUBA1A TUBA4A TUBA1C ARG1 | 1.80e-09 | 381 | 43 | 10 | CID000003121 |
| Drug | NSC 370147 | 1.80e-09 | 28 | 43 | 5 | CID000182762 | |
| Drug | epo906 | 1.82e-09 | 114 | 43 | 7 | CID000388945 | |
| Drug | bp U | 2.17e-09 | 29 | 43 | 5 | CID000368697 | |
| Drug | ddGDP | 2.17e-09 | 29 | 43 | 5 | CID000134739 | |
| Drug | oxibendazole | 2.17e-09 | 29 | 43 | 5 | CID000004622 | |
| Drug | AAGTP | 2.18e-09 | 64 | 43 | 6 | CID000656407 | |
| Drug | AC1NBBHE | 2.60e-09 | 30 | 43 | 5 | CID004490620 | |
| Drug | eleutherobin | 2.60e-09 | 30 | 43 | 5 | CID006918335 | |
| Drug | azatoxin | 2.60e-09 | 30 | 43 | 5 | CID000125383 | |
| Drug | NSC617668 | 2.60e-09 | 30 | 43 | 5 | CID000357989 | |
| Drug | citostal | 2.60e-09 | 30 | 43 | 5 | CID000018991 | |
| Drug | thiocolchicine | 2.60e-09 | 30 | 43 | 5 | CID000017648 | |
| Drug | tropone | 3.10e-09 | 31 | 43 | 5 | CID000010881 | |
| Drug | NSC609395 | 3.10e-09 | 31 | 43 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 3.10e-09 | 31 | 43 | 5 | CID000100524 | |
| Drug | AC7700 | 3.10e-09 | 31 | 43 | 5 | CID006918404 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 3.10e-09 | 31 | 43 | 5 | CID000032851 | |
| Drug | AC1L3V8I | 3.10e-09 | 31 | 43 | 5 | CID000122777 | |
| Drug | NSC332598 | 3.10e-09 | 31 | 43 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 3.10e-09 | 31 | 43 | 5 | CID000023678 | |
| Drug | 3,4-dihydroxyphenylalanine | 3.30e-09 | 199 | 43 | 8 | CID000000836 | |
| Drug | AC1L1G95 | 3.66e-09 | 32 | 43 | 5 | CID000003583 | |
| Drug | E2-3,4-Q | 3.66e-09 | 32 | 43 | 5 | CID000067402 | |
| Drug | NSC153858 | 3.66e-09 | 32 | 43 | 5 | CID000547450 | |
| Drug | 2-demethylcolchicine | 3.66e-09 | 32 | 43 | 5 | CID000023757 | |
| Drug | CA4P | 4.31e-09 | 33 | 43 | 5 | CID000370232 | |
| Drug | taltobulin | 4.31e-09 | 33 | 43 | 5 | CID006918637 | |
| Drug | mebendazole | 4.31e-09 | 33 | 43 | 5 | CID000004030 | |
| Drug | triethyllead | 5.05e-09 | 34 | 43 | 5 | CID006328106 | |
| Drug | NSC376450 | 5.05e-09 | 34 | 43 | 5 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 5.05e-09 | 34 | 43 | 5 | CID000161091 | |
| Drug | discodermolide | 5.88e-09 | 35 | 43 | 5 | CID000643668 | |
| Drug | AC1O5Y0F | 7.87e-09 | 37 | 43 | 5 | CID006442852 | |
| Drug | DTAF | 7.87e-09 | 37 | 43 | 5 | CID000123934 | |
| Drug | albendazole | 7.87e-09 | 37 | 43 | 5 | CID000002082 | |
| Drug | baccatin III | 7.87e-09 | 37 | 43 | 5 | CID000065366 | |
| Drug | LEO275 | 7.92e-09 | 79 | 43 | 6 | CID000018140 | |
| Drug | laulimalide | 9.06e-09 | 38 | 43 | 5 | CID006918457 | |
| Drug | gnoscopine | 9.06e-09 | 38 | 43 | 5 | CID000004544 | |
| Drug | colchiceine | 9.06e-09 | 38 | 43 | 5 | CID000010156 | |
| Drug | erianin | 1.04e-08 | 39 | 43 | 5 | CID000356759 | |
| Drug | Dolastatin 10 | 1.04e-08 | 39 | 43 | 5 | CID000100208 | |
| Drug | AC1L8GZ1 | 1.18e-08 | 40 | 43 | 5 | CID000381235 | |
| Drug | indanone | 1.35e-08 | 41 | 43 | 5 | CID000006735 | |
| Disease | microlissencephaly (implicated_via_orthology) | 1.02e-23 | 8 | 43 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 1.02e-23 | 8 | 43 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 1.02e-23 | 8 | 43 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 2.22e-17 | 27 | 43 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 1.15e-08 | 4 | 43 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 6.22e-06 | 3 | 43 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | childhood absence epilepsy (implicated_via_orthology) | 3.10e-05 | 6 | 43 | 2 | DOID:1825 (implicated_via_orthology) | |
| Disease | Sleep Disorders | 4.34e-05 | 7 | 43 | 2 | C0851578 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 4.34e-05 | 7 | 43 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Subwakefullness Syndrome | 4.34e-05 | 7 | 43 | 2 | C0751511 | |
| Disease | Sleep-Related Neurogenic Tachypnea | 4.34e-05 | 7 | 43 | 2 | C0751510 | |
| Disease | Short Sleeper Syndrome | 4.34e-05 | 7 | 43 | 2 | C0751509 | |
| Disease | Long Sleeper Syndrome | 4.34e-05 | 7 | 43 | 2 | C0751508 | |
| Disease | Sleep Wake Disorders | 4.34e-05 | 7 | 43 | 2 | C4042891 | |
| Disease | Peripheral T-Cell Lymphoma | 9.27e-05 | 10 | 43 | 2 | C0079774 | |
| Disease | Granulomatous Slack Skin | 4.70e-04 | 22 | 43 | 2 | C0376407 | |
| Disease | Lymphoma, T-Cell, Cutaneous | 5.15e-04 | 23 | 43 | 2 | C0079773 | |
| Disease | beta-aminoisobutyric acid measurement | 5.61e-04 | 24 | 43 | 2 | EFO_0010464 | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 5.61e-04 | 24 | 43 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | Bipolar Disorder | 6.27e-04 | 477 | 43 | 5 | C0005586 | |
| Disease | L-arginine measurement | 7.11e-04 | 27 | 43 | 2 | EFO_0006524 | |
| Disease | Myopathy | 8.79e-04 | 30 | 43 | 2 | C0026848 | |
| Disease | human immunodeficiency virus infectious disease (is_marker_for) | 1.27e-03 | 36 | 43 | 2 | DOID:526 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IWAVIKPGTSFGISV | 566 | O00555 | |
| SIIFAVGKGFPWVEV | 51 | Q6P047 | |
| KPFWVLVVVGGVLAC | 151 | P10747 | |
| EKGFIWGFLGPVCAI | 681 | Q9UHX3 | |
| LKFCIVGWGVPAVVV | 736 | Q8IZP9 | |
| PWHKTVTIGFGVTLC | 41 | Q9NR28 | |
| GSVFEVVWAAIKPGS | 556 | Q00975 | |
| GFSWVTPCISAKDIV | 161 | P05089 | |
| CWKTSIGPAFVALIG | 56 | Q149M9 | |
| PVVPGFCCTVGVDWK | 731 | O75140 | |
| FFWKQPGTLEVVSGC | 351 | Q09327 | |
| WFKLVGSSPIFHGCV | 886 | O60333 | |
| LTFIGIPGFESVQCW | 16 | A6NMU1 | |
| FAHWEGGCTVKIPVA | 751 | Q8TET4 | |
| FWKTPVECGIGFTII | 451 | Q01650 | |
| GFTIKWDIPGIFVAS | 1056 | Q8WWI1 | |
| PFWTKLVVVAIGFTG | 196 | Q5T0T0 | |
| PFWTKLVVVAIGFTG | 196 | Q8TCQ1 | |
| STGVFIGWTPFLCIV | 201 | Q9UGF6 | |
| VLEWCTGTVPIGEFL | 2766 | Q13315 | |
| WVPGVPTCIKKAFIG | 836 | P20023 | |
| GLPVLFTGTWVSCKL | 251 | Q02643 | |
| GIPSVFWVGSKKTCF | 491 | Q9NPG1 | |
| CKVFLGGVPWDITEA | 311 | Q9BZB8 | |
| GFPWELVICAAVVGF | 646 | Q96PC5 | |
| CKRVTEPGAFWGLVF | 481 | Q2M3M2 | |
| QEGFICTWGRPGKVV | 551 | Q8TBZ3 | |
| PFVSVTDLIGGKWIF | 136 | P34969 | |
| IQFVDWCPTGFKVGI | 341 | P0DPH8 | |
| GVTDIWPVGVVAFLC | 1776 | Q15772 | |
| WPVGVVAFLCLTGIS | 1781 | Q15772 | |
| VWKICPILKGVGFTV | 131 | Q01959 | |
| VTAWRKICPIFEGIG | 101 | Q9NSD5 | |
| VGIKSKAVVVPWGSC | 81 | Q8TCT8 | |
| IQFVDWCPTGFKVGI | 341 | P0DPH7 | |
| GDWGKTFTVPIVEVT | 536 | Q8N5H7 | |
| IQFVDWCPTGFKVGI | 341 | Q71U36 | |
| IQFVDWCPTGFKVGI | 341 | Q6PEY2 | |
| IQFVDWCPTGFKVGI | 341 | P68363 | |
| IQFVDWCPTGFKVGI | 341 | Q9BQE3 | |
| IQFVDWCPTGFKVGI | 341 | Q9NY65 | |
| IQFVDWCPTGFKVGI | 341 | P68366 | |
| VCGPLFEEELTFWGI | 121 | Q03721 | |
| DTFFGIWTCLGAPIK | 216 | P52961 |